Search - Prime Therapeutics
-
Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Jared Scripture, health outcomes scientist, shares more about the study “Leveraging Publicly Available SDOH Measures to Segment Members and Quantify Differences in Diabetic Medication Adherence: A...
Prime Article: Perspectives -
Lead authors Erin Ventura and Alina Liang share more about the study “Evaluating the 10-Year Impact of an Immunoglobulin Utilization Management and Dose Optimization Program in the Managed Care...
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Designed for unions, delivered with care At Prime Therapeutics (Prime), we built our model around transparency, flexibility and aligned incentives from the start. We don’t just help unions respond...